Related Experiment Video
Updated: Aug 5, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
MITD1 restricts HIV-1 release by targeting ESCRT-III proteins
Jim Zoladek1, Marion Cannac2, Claire Lacouture1
1Institut de Recherche en Infectiologie de Montpellier (IRIM), Montpellier University, Centre National de la Recherche Scientifique (CNRS) UMR 9004, INSERM, Montpellier, France.
Abstract:
HIV-1 release from infected cells requires coordinated action of the viral Gag protein and the host endosomal sorting complexes required for transport (ESCRT) machinery. How innate immunity regulates ESCRT function to limit viral egress remains unclear. Here, we show that MITD1, a cell type-specific interferon-stimulated gene, is a potent inhibitor of ESCRT-dependent HIV-1 budding. MITD1 engages ESCRT-III subunits CHMP1B and CHMP4B, driving their incorporation into aggregates and impairing ESCRT-III assembly during HIV-1 budding. This disrupts the final steps of virion release, causing an accumulation of immature particles at the plasma membrane. MITD1 overexpression reduces HIV-1 release from cell lines, primary peripheral blood mononuclear cells (PBMCs), and human microglia, while sparing the release of ESCRT-independent viruses. These findings establish MITD1 as an interferon-stimulated restriction factor that limits HIV-1 egress by perturbing ESCRT-III assembly.
More Related Videos
10:12Measuring Endoplasmic Reticulum Stress and Unfolded Protein Response in HIV-1 Infected T-Cells and Analyzing its Role in HIV-1 Replication
Published on: June 14, 2024
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Intralumenal Vesicles and Multivesicular Bodies
Inhibitors Of Virion Release